| (210) | Number of the EPO application | 17743136 |
| (220) | Filing date of the EPO application | 2017.07.11 |
| (80) | EPO patent specification publication (B) | EPB nr. 37/2023, 2023.09.13 |
| (110) | EPO patent number | 3481845 |
| (21) | Number of the application | e 2019 0583 |
| (71) | Name(s) of applicant(s), code of the country | SAGE THERAPEUTICS, INC., US; |
| (72) | Name(s) of inventor(s), code of the country | ROBICHAUD Albert J., US;
MARTINEZ BOTELLA Gabriel, US;
HARRISON Boyd L., US;
SALITURO Francesco G., US;
GRIFFIN Andrew, CA;
BLANCO-PILLADO Maria Jesus, US; |
| (73) | Name(s) of owner(s), code of the country | SAGE THERAPEUTICS, INC., US; |
| (54) | Title of the invention | C17, C20, AND C21 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07J 7/00 (2006.01.01); C07J 17/00 (2006.01.01); C07J 9/00 (2006.01.01); C07J 1/00 (2006.01.01); C07J 43/00 (2006.01.01); C07J 41/00 (2006.01.01); A61K 31/565 (2006.01.01); A61K 31/57 (2006.01.01); A61P 5/00 (2006.01.01); A61P 25/08 (2006.01.01); A61P 25/18 (2006.01.01); A61P 25/20 (2006.01.01); A61P 25/28 (2006.01.01); A61P 25/00 (2006.01.01); A61K 31/58 (2006.01.01); A61K 31/575 (2006.01.01); A61K 31/573 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.06.30 |
| (30) | Priority | 201662360813 P, 2016.07.11, US; 201662360847 P, 2016.07.11, US; 201662424083 P, 2016.11.18, US |
| (86) | International application | PCT/US2017/041600, 2017.07.11 |
| (87) | International publication | WO 2018/013613, 2018.01.18 |